Vutrisiran

Vutrisiran is a medication used to treat adults with hereditary transthyretin-mediated amyloidosis (hATTR). It is a synthetic small interfering ribonucleic acid (siRNA) molecule designed to reduce the production of transthyretin (TTR) protein by targeting the messenger RNA (mRNA) that provides the instructions for making TTR. By reducing TTR production, Vutrisiran is believed to reduce the buildup of TTR amyloid deposits in the body, which may improve symptoms and slow disease progression.

Vutrisiran, sold under the brand name Amvuttra, is a medication used to treat a specific hereditary condition called familial amyloidosis polyneuropathy (hATTR) in adults [1, 2]. Here's a closer look at its key aspects:

Condition:

  • Vutrisiran targets hATTR, a rare inherited disorder where abnormal proteins build up in nerves and other tissues, leading to progressive damage and dysfunction [1, 2]. This buildup of proteins (amyloid) causes various symptoms, such as numbness, tingling, pain, and weakness in the legs and feet, eventually affecting other organs like the heart and digestive system [2].

Mechanism of Action:

  • Vutrisiran belongs to a relatively new drug class called small interfering RNAs (siRNAs) [1]. siRNAs target specific messenger RNA (mRNA) molecules, which are the instructions cells use to produce proteins.
  • In hATTR, vutrisiran targets the mRNA responsible for the production of the abnormal protein that builds up in the body [2]. By blocking this mRNA, vutrisiran helps to reduce the production of the protein, thereby slowing down disease progression and potentially improving symptoms.

Administration:

  • Vutrisiran is administered as an injection under the skin in the doctor's office, typically once every three months [2, 4].

Important Considerations:

  • Vutrisiran is a recently approved medication, and long-term effects are still being studied [5].
  • Common side effects include injection site reactions (pain, redness, swelling), fatigue, headache, and respiratory infections [2, 4].
  • Vutrisiran can interact with other medications, so it's crucial to inform your doctor about all medications, supplements, and herbal products you're taking [4].
  • It may not be suitable for everyone, particularly people with severe liver impairment or pregnant women [2].
Anatomical Therapeutic Chemical Classification
N - Nervous system
N07 Other nervous system drugs
N07X - Other nervous system drugs
N07XX Other nervous system drugs
External Links